SRF（503806）株式概要
SRFリミテッドは、テクニカル・テキスタイル、化学品、包装用フィルム、その他ポリマーの製造、購入、販売を行っている。 詳細
503806 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
SRF Limited 競合他社
価格と性能
| 過去の株価 | |
|---|---|
| 現在の株価 | ₹2,774.85 |
| 52週高値 | ₹3,263.00 |
| 52週安値 | ₹2,313.75 |
| ベータ | 0.054 |
| 1ヶ月の変化 | 1.53% |
| 3ヶ月変化 | 12.29% |
| 1年変化 | -12.71% |
| 3年間の変化 | 26.87% |
| 5年間の変化 | 78.83% |
| IPOからの変化 | 90,878.69% |
最新ニュース
ナラティブの更新 • Jun 22
503806: Rich P/E And Softer Margins Will Likely Restrain Future Upside
Analysts have kept SRF's price target steady at ₹2,200, with the change in assumptions reflecting a lower discount rate, more moderate revenue growth and profit margin expectations, and a higher future P/E multiple to balance these factors. What's in the News for SRF SRF has scheduled a board meeting on May 5, 2026, to consider and approve the audited financial results for the quarter and year ended March 31, 2026.
ナラティブの更新 • Jun 06
503806: Expanded Capital Outlay Will Support Long Term Performance
Analysts have revised their price target for SRF to ₹3,579 from ₹3,841, citing updated assumptions for revenue growth, profit margins, and the discount rate, while keeping the future P/E expectation broadly similar. What's in the News SRF has scheduled a board meeting on May 5, 2026 to consider and approve the audited financial results for the quarter and year ended March 31, 2026.
ナラティブの更新 • May 22
503806: Expanded Capital Outlay And Dividend Potential Will Support Future Upside
Analysts have trimmed their fair value estimate for SRF from about ₹3,155.83 to ₹2,990.35, reflecting updated assumptions around discount rate, revenue growth, profit margin and future P/E expectations. What's in the News Board meeting scheduled for May 5, 2026, to consider and approve audited financial results for the quarter and year ended March 31, 2026 (company filing).Recent updates
ナラティブの更新 • Jun 22
503806: Rich P/E And Softer Margins Will Likely Restrain Future Upside
Analysts have kept SRF's price target steady at ₹2,200, with the change in assumptions reflecting a lower discount rate, more moderate revenue growth and profit margin expectations, and a higher future P/E multiple to balance these factors. What's in the News for SRF SRF has scheduled a board meeting on May 5, 2026, to consider and approve the audited financial results for the quarter and year ended March 31, 2026.ナラティブの更新 • Jun 06
503806: Expanded Capital Outlay Will Support Long Term Performance
Analysts have revised their price target for SRF to ₹3,579 from ₹3,841, citing updated assumptions for revenue growth, profit margins, and the discount rate, while keeping the future P/E expectation broadly similar. What's in the News SRF has scheduled a board meeting on May 5, 2026 to consider and approve the audited financial results for the quarter and year ended March 31, 2026.ナラティブの更新 • May 22
503806: Expanded Capital Outlay And Dividend Potential Will Support Future Upside
Analysts have trimmed their fair value estimate for SRF from about ₹3,155.83 to ₹2,990.35, reflecting updated assumptions around discount rate, revenue growth, profit margin and future P/E expectations. What's in the News Board meeting scheduled for May 5, 2026, to consider and approve audited financial results for the quarter and year ended March 31, 2026 (company filing).ナラティブの更新 • Apr 30
503806: Future P/E Compression Will Likely Cap Upside Despite Margin Support
The analyst price target for SRF has been adjusted from ₹2,249.74 to ₹2,200.00 as analysts factor in updated assumptions on discount rate, revenue growth, profit margin and future P/E. What's in the News SRF has scheduled a board meeting on May 05, 2026 to consider and approve the audited financial results for the quarter and year ended March 31, 2026 (company filing).ナラティブの更新 • Apr 08
503806: Fair View As Higher Margins Offset Lower Future P/E Multiple
Analysts have raised their fair value estimate for SRF slightly, from ₹2,239.45 to ₹2,249.74. This reflects updated assumptions for revenue growth, profit margins, a lower assumed discount rate, and a reduced future P/E multiple.ナラティブの更新 • Mar 24
503806: Elevated P E And Margins Will Likely Restrain Future Returns
Analysts have modestly increased their fair value estimate for SRF from ₹2,218.36 to ₹2,239.45, citing updated assumptions regarding revenue growth, profit margins, the discount rate, and future P/E, which together support a slightly higher price target. What's in the News SRF's board approved the appointment of Mr. Samir Kashyap as Chief Financial Officer, effective January 27, 2026.ナラティブの更新 • Mar 09
503806: Elevated P E And Modest Margins Will Likely Restrain Future Returns
Analysts now set their fair value estimate for SRF at ₹2,218, compared with the previous ₹2,244. This reflects updated assumptions around discount rate, revenue growth, profit margins and future P/E expectations.ナラティブの更新 • Feb 23
503806: Elevated P E And Modest Margin Outlook Will Likely Pressure Returns
Analysts have slightly raised their price target on SRF to ₹2,244, citing updated assumptions for the discount rate, revenue growth, profit margin and future P/E. These changes keep their fair value view broadly unchanged in headline terms but reflect a modestly adjusted risk and earnings profile.ナラティブの更新 • Feb 09
503806: Lower Margins And Rich P E Will Likely Pressure Returns
Analysts have raised their price target on SRF to ₹2,244 from ₹2,213, citing updated assumptions on the discount rate, revenue growth, profit margins and a higher future P/E multiple. What's in the News The board has approved the appointment of Mr. Samir Kashyap as Chief Financial Officer, effective January 27, 2026.ナラティブの更新 • Jan 24
503806: New Pharma Plant And CFO Appointment Will Support Future Upside
Analysts have trimmed their price target on SRF to ₹3,155.83 from ₹3,183.00, reflecting slightly more conservative assumptions on revenue growth, profit margin and future P/E, as well as a marginally higher discount rate. What's in the News Board meeting on January 20, 2026 to review unaudited financial results for the quarter and nine months ended December 31, 2025, consider a new pharma intermediate plant project, and discuss a second interim dividend for FY 2025-26 (company filing).ナラティブの更新 • Jan 10
503806: Future Capacity Expansion And CFO Transition Will Support Long Term Prospects
Analysts have kept their fair value estimate for SRF steady at ₹3,841, with only small tweaks to assumptions such as the discount rate, revenue growth, profit margin and future P/E that feed into the updated target. This signals broadly consistent expectations compared with prior research.ナラティブの更新 • Dec 26
503806: Future Specialty Fluoropolymer Capacity Expansion May Support Long Term Profitability
Analysts have modestly raised their price target on SRF to a new level, in line with incremental improvements in projected revenue growth, profit margins, and a slightly lower future valuation multiple, signaling a cautiously stronger outlook for the stock. What's in the News Chief Financial Officer Rahul Jain will step down from his role at the close of business on 12 December 2025, with SRF initiating the process to identify a successor and ensure a smooth transition (Key Developments).ナラティブの更新 • Dec 12
503806: Lower Discount Rate May Support Stronger Long Term Profitability
Analysts have raised their fair value estimate for SRF by approximately $191 to $3,841 per share, citing a modestly lower discount rate and slightly higher long term profit margin expectations that more than offset a small reduction in projected revenue growth. What's in the News Chief Financial Officer Rahul Jain will step down from his role at the close of business on 12 December 2025.ナラティブの更新 • Nov 27
503806: CFO Transition And New Facility Approval Will Drive Upside Ahead
Analysts have adjusted their price target for SRF slightly upward from $3,182.93 to $3,183.00, citing minor changes in underlying financial assumptions such as discount rate and projected margin. What's in the News Chief Financial Officer Rahul Jain will step down at the close of business on December 12, 2025.ナラティブの更新 • Nov 12
503806: Upcoming CFO Departure And Facility Decision Will Shape Outlook
Analysts have raised their price target for SRF from $3,138.07 to $3,182.93, citing updated forecasts that reflect slight adjustments in growth and profitability assumptions. What's in the News SRF Limited's Chief Financial Officer, Rahul Jain, announced he will step down from his position at the close of business on December 12, 2025.ナラティブの更新 • Oct 29
New Facility And Supply Chain Moves Will Drive Balanced Opportunity Ahead
Analysts have slightly raised their price target for SRF from $3,137.83 to $3,138.07, citing improved profit margin projections as well as a modest increase in anticipated revenue growth. What's in the News SRF Limited will hold a Board Meeting on October 27, 2025, to consider and approve the un-audited financial results for the quarter and half year ended September 30, 2025.ナラティブの更新 • Oct 15
Sustainability And Capacity Upgrades Will Transform Specialty Chemicals
Analysts have increased their price target for SRF from $3,104.79 to $3,137.83, reflecting updated expectations for the company's financial outlook. What's in the News The Chemours Company and SRF Limited have signed strategic agreements to enhance the global supply chain for fluoropolymers and fluoroelastomers (Key Developments).ナラティブの更新 • Sep 05
Sustainability And Capacity Upgrades Will Transform Specialty Chemicals
With no meaningful change in either the discount rate or forward P/E multiple, analysts have maintained SRF's fair value estimate at ₹3105. What's in the News SRF Limited has entered into strategic agreements with The Chemours Company to strengthen Chemours' global supply chain for fluoropolymers and fluoroelastomers, leveraging SRF's manufacturing capabilities.
新しいナラティブ • Nov 28
Specialty Chemicals Innovations And Global Demand Empower Revenue Growth Journey
SRF's Specialty Chemicals growth and increased production should drive revenue and improve margins due to new product launches and efficiency gains.株主還元
| 503806 | IN Chemicals | IN 市場 | |
|---|---|---|---|
| 7D | -0.7% | -1.9% | -0.9% |
| 1Y | -12.7% | -6.0% | -2.1% |
業界別リターン: 503806過去 1 年間で-6 % の収益を上げたIndian Chemicals業界を下回りました。
リターン対市場: 503806は、過去 1 年間で-2.1 % のリターンを上げたIndian市場を下回りました。
価格変動
| 503806 volatility | |
|---|---|
| 503806 Average Weekly Movement | 3.8% |
| Chemicals Industry Average Movement | 6.2% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.2% |
| 10% least volatile stocks in IN Market | 3.9% |
安定した株価: 503806 、 Indian市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。
時間の経過による変動: 503806の 週次ボラティリティ ( 4% ) は過去 1 年間安定しています。
会社概要
| 設立 | 従業員 | CEO（最高経営責任者 | ウェブサイト |
|---|---|---|---|
| 1970 | 7,686 | Ashish Ram | www.srf.com |
テクニカルテキスタイル、ケミカル、包装用フィルム、その他ポリマーの製造、仕入、販売。テクニカル・テキスタイル事業、化学品事業、包装用フィルム事業、その他事業を展開。ポリエステルとナイロンのタイヤコード、ベルト、コーティング、ラミネート織物、工業用とポリエステルの工業用糸を提供している。また、「フロロン」ブランドでルームエアコン、カーエアコン、冷蔵庫、冷凍機用冷媒などのフッ素化学品、「ダイメル」ブランドで医薬品分野向け推進剤を提供している；フロニオ」ブランドでは、医薬用溶剤、農薬原料、金属脱脂、ステンレスやガラスのエッチング、発泡剤、ドライクリーニングなど様々な用途に使用される工業用化学品、「フロニオ」ブランドでは、自動車、化学処理・プラント建設、建築、電気・電子工学、半導体、医薬・医療用途のPTFE樹脂を提供している。さらに、農薬・医薬用途の先端中間体、PETLARおよびOPLARブランドの二軸延伸ポリエチレンテレフタレートおよび二軸延伸ポリプロピレンフィルムも提供している。また、不動産の所有・賃貸事業も行っている。インド、米国、南アフリカ、英国、イタリア、インドネシア、アラブ首長国連邦、韓国、ドイツ、タイ、ハンガリー、スイス、ベルギー、その他国際的に事業を展開している。SRF Limited の前身は Shri Ram Fibres で、1990 年に社名を SRF Limited に変更した。1970年に設立され、本社はインドのグルグラムにある。SRF社はKAMAホールディングスの子会社である。
SRF Limited 基礎のまとめ
| 503806 基礎統計学 | |
|---|---|
| 時価総額 | ₹822.53b |
| 収益（TTM） | ₹18.35b |
| 売上高(TTM) | ₹157.87b |
44.8x
PER（株価収益率5.2x
P/Sレシオ503806 は割高か？
公正価値と評価分析を参照収益と収入
| 503806 損益計算書（TTM） | |
|---|---|
| 収益 | ₹157.87b |
| 売上原価 | ₹81.97b |
| 売上総利益 | ₹75.89b |
| その他の費用 | ₹57.54b |
| 収益 | ₹18.35b |
直近の収益報告
Mar 31, 2026
次回決算日
該当なし
| 一株当たり利益（EPS） | 61.91 |
| グロス・マージン | 48.07% |
| 純利益率 | 11.63% |
| 有利子負債／自己資本比率 | 35.6% |
503806 の長期的なパフォーマンスは？
過去の実績と比較を見る配当金
0.4%
現在の配当利回り15%
配当性向企業分析と財務データの現状
| データ | 最終更新日（UTC時間） |
|---|---|
| 企業分析 | 2026/07/10 21:46 |
| 終値 | 2026/07/10 00:00 |
| 収益 | 2026/03/31 |
| 年間収益 | 2026/03/31 |
データソース
企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。
| パッケージ | データ | タイムフレーム | 米国ソース例 |
|---|---|---|---|
| 会社財務 | 10年 |
| |
| アナリストのコンセンサス予想 | +プラス3年 |
|
|
| 市場価格 | 30年 |
| |
| 所有権 | 10年 |
| |
| マネジメント | 10年 |
| |
| 主な進展 | 10年 |
|
* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。
特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。
分析モデルとスノーフレーク
このレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。
シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。
業界およびセクターの指標
私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。
アナリスト筋
SRF Limited 27 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。45
| アナリスト | 機関 |
|---|---|
| null null | 360 ONE Capital Market Private Limited |
| Kumar Saumya Singh | Ambit Capital |
| Nitin Bhasin | Ambit Capital |